Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Last weekend, the world’s biggest cancer research conference – ASCO 2014 – took place in the US. Thousands of doctors and scientists from around the world gathered to...
Promising results in phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma
A new cancer vaccine (IMA950) for glioblastoma has met the two primary endpoints of safety and immunogenicity in a Cancer Research UK trial.
This entry is part 4 of 4 in the series Cancer and Infections
The fourth post in our Cancer and Infections series is a continuation of the Epstein-Barr virus (EBV)...
Harnessing the body’s own immune system to fight against cancer is a tantalising prospect, and one which our own scientists are working hard on.
The field of...